Financial statement analysis and common stock valuation
Financial Analyst
Stock Analysis on Net
If you are an investor who values fundamental analysis, you are in the right place. If you need comprehensive financial ratios, read on. You already know that the analysis of financial statements allows you to buy cheap and sell high, now it’s time to put it into practice. Stock Analysis on Net is here for you.
Today, try for free:
Johnson & Johnson (NYSE:JNJ)
Balance Sheet: Assets
The assets reports major classes and amounts of resources owned or controlled by Johnson & Johnson.
Common Stock Valuation Ratios
Relative valuation technique determine the value of Johnson & Johnson by comparing it to similar entities (like industry or sector) on the basis of several relative ratios that compare its stock price to relevant variables that affect the stock value, such as earnings, book value, and sales.
Price to FCFE (P/FCFE)
Free cash flow to equity is the cash flow available to Johnson & Johnson equity holders after all operating expenses, interest, and principal payments have been paid and necessary investments in working and fixed capital have been made.
Common Stock Valuation Ratios
Quarterly Data
Relative valuation technique determine the value of Johnson & Johnson by comparing it to similar entities (like industry or sector) on the basis of several relative ratios that compare its stock price to relevant variables that affect the stock value, such as earnings, book value, and sales.
Long-term Trends
Balance Sheet: Liabilities and Stockholders’ Equity
The liabilities and stockholders’ equity reports major classes and amounts of external claims on assets and owners’ capital contributions, and other internally generated sources of capital.
Analysis of Long-term (Investment) Activity Ratios
Quarterly Data
Measures how efficiently Johnson & Johnson generates revenues from its investments in fixed or total assets.
Income Statement
Quarterly Data
The income statement (statement of earnings) reports on the performance of Johnson & Johnson, the result of its operating activities.
DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
An approach to decomposing Johnson & Johnson return on equity, return on assets, and net profit margin ratio as the product of other financial ratios.
Common-Size Income Statement
Income statement components (revenues and expenses) shown as percentage of total sales.
Analysis of Short-term (Operating) Activity Ratios
Evaluates revenues and output generated by the Johnson & Johnson assets. Operating performance ratios describe the relationship between the Johnson & Johnson level of operations and the assets needed to sustain operating activities.
Analysis of Long-term (Investment) Activity Ratios
Measures how efficiently Johnson & Johnson generates revenues from its investments in fixed or total assets.
Analysis of Reportable Segments
Johnson & Johnson operates in 2 segments: Innovative Medicine and MedTech.
What’s new
Thursday, February 26, 2026
Thermo Fisher Scientific Inc. (NYSE:TMO) annual report
for fiscal year ended December 31, 2025
Thursday, February 26, 2026
Pfizer Inc. (NYSE:PFE) annual report
for fiscal year ended December 31, 2025
Thursday, February 26, 2026
Eaton Corp. plc (NYSE:ETN) annual report
for fiscal year ended December 31, 2025
Thursday, February 26, 2026
Intuit Inc. (NASDAQ:INTU) quarterly report
for quarterly period ended January 31, 2026
Wednesday, February 25, 2026
Linde plc (NASDAQ:LIN) annual report
for fiscal year ended December 31, 2025
Wednesday, February 25, 2026
Synopsys Inc. (NASDAQ:SNPS) quarterly report
for quarterly period ended January 31, 2026